首页> 外文期刊>Gastroenterology >No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates
【24h】

No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates

机译:饮食减少可发酵的,吸收不良的短链碳水化合物后,自我报告的非芹菜型麸质敏感性患者中的麸质没有影响

获取原文
获取原文并翻译 | 示例
           

摘要

Background & Aims Patients with non-celiac gluten sensitivity (NCGS) do not have celiac disease but their symptoms improve when they are placed on gluten-free diets. We investigated the specific effects of gluten after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates (fermentable, oligo-, di-, monosaccharides, and polyols [FODMAPs]) in subjects believed to have NCGS. Methods We performed a double-blind cross-over trial of 37 subjects (aged 24-61 y, 6 men) with NCGS and irritable bowel syndrome (based on Rome III criteria), but not celiac disease. Participants were randomly assigned to groups given a 2-week diet of reduced FODMAPs, and were then placed on high-gluten (16 g gluten/d), low-gluten (2 g gluten/d and 14 g whey protein/d), or control (16 g whey protein/d) diets for 1 week, followed by a washout period of at least 2 weeks. We assessed serum and fecal markers of intestinal inflammation/injury and immune activation, and indices of fatigue. Twenty-two participants then crossed over to groups given gluten (16 g/d), whey (16 g/d), or control (no additional protein) diets for 3 days. Symptoms were evaluated by visual analogue scales. Results In all participants, gastrointestinal symptoms consistently and significantly improved during reduced FODMAP intake, but significantly worsened to a similar degree when their diets included gluten or whey protein. Gluten-specific effects were observed in only 8% of participants. There were no diet-specific changes in any biomarker. During the 3-day rechallenge, participants' symptoms increased by similar levels among groups. Gluten-specific gastrointestinal effects were not reproduced. An order effect was observed. Conclusions In a placebo-controlled, cross-over rechallenge study, we found no evidence of specific or dose-dependent effects of gluten in patients with NCGS placed diets low in FODMAPs. www.anzctr.org.au. ACTRN12610000524099.
机译:背景与目的非麸质麸质敏感性(NCGS)患者不患有乳糜泻,但无麸质饮食可改善症状。我们研究了在饮食中减少可发酵,吸收不良的短链碳水化合物(可发酵,低聚,二糖,单糖和多元醇[FODMAPs])后面筋的特殊作用,这些受试者被认为患有NCGS。方法我们对37名患有NCGS和肠易激综合征(基于Rome III标准)但未患有乳糜泻的受试者(年龄在24-61岁,6名男性)进行了一项双盲交叉试验。将参与者随机分配到接受2周降低FODMAP饮食的组中,然后分别置于高麸质(16 g麸质/ d),低麸质(2 g麸质/ d和14 g乳清蛋白/ d)上,或对照(16 g乳清蛋白/ d)饮食1周,然后至少2周为清除期。我们评估了肠道炎症/损伤和免疫激活的血清和粪便标志物,以及疲劳指数。然后有22名参与者分成三组,分别接受麸质(16 g / d),乳清(16 g / d)或对照(无其他蛋白质)饮食。通过视觉模拟量表评估症状。结果在所有参与者中,FODMAP摄入减少时,胃肠道症状持续且显着改善,但当他们的饮食中包括麸质或乳清蛋白时,胃肠道症状显着恶化至相似的程度。仅8%的参与者观察到了面筋特异性作用。任何生物标志物都没有饮食特定的变化。在为期3天的再挑战期间,参与者的症状在各组之间的升高程度相似。面筋特异性胃肠道作用未得到再现。观察到有序效应。结论在安慰剂对照,交叉再挑战研究中,我们没有发现在FGSMAP含量低的NCGS患者中面筋的特异性或剂量依赖性作用的证据。 www.anzctr.org.au。 ACTRN12610000524099。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号